Cytogenetics in reproductive medicine: The contribution of comparative genomic hybridization (CGH)
- 20 February 2003
- Vol. 25 (3) , 289-300
- https://doi.org/10.1002/bies.10232
Abstract
Cytogenetic research has had a major impact on the field of reproductive medicine, providing an insight into the frequency of chromosomal abnormalities that occur during gametogenesis, embryonic development and pregnancy. In humans, aneuploidy has been found to be relatively common during fetal life, necessitating prenatal screening of high‐risk pregnancies. Aneuploidy rates are higher still during the preimplantation stage of development. An increasing number of IVF laboratories have attempted to improve pregnancy rates by using preimplantation genetic diagnosis (PGD) to ensure that the embryos transferred to the mother are chromosomally normal. This paper reviews some of the techniques that are key to the detection of aneuploidy in reproductive samples including comparative genomic hybridization (CGH). CGH has provided an unparalleled insight into the nature of chromosome imbalance in human embryos and polar bodies. The clinical application of CGH for the purposes of PGD and the future extensions of the methodology, including DNA microarrays, are discussed. BioEssays 25:289–300, 2003.Keywords
This publication has 78 references indexed in Scilit:
- Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervalsGenes, Chromosomes and Cancer, 1999
- First Pregnancies After Preconception Diagnosis of Translocations of Maternal OriginFertility and Sterility, 1998
- Detection of DNA gains and losses in primary endometrial carcinomas by comparative genomic hybridizationGenes, Chromosomes and Cancer, 1997
- Detection of chromosomal DNA gains and losses in testicular germ cell tumors by comparative genomic hybridizationGenes, Chromosomes and Cancer, 1996
- Computer image analysis of comparative genomic hybridizationCytometry, 1995
- Swedish survey on extra structurally abnormal chromosomes in 39 105 consecutive prenatal diagnoses: Prevalence and characterization by fluorescence in situ hybridizationPrenatal Diagnosis, 1994
- Characterization of marker chromosomes by microdissection and fluorescence in situ hybridizationPrenatal Diagnosis, 1994
- Detection of Fetal Trisomies 21 and 18 From Maternal Blood Using Triple Gradient and Magnetic Cell SortingAmerican Journal of Reproductive Immunology, 1993
- First trimester prenatal diagnosis of trisomy 21 in fetal cells from maternal bloodThe Lancet, 1992
- Chorionic villus metaphase chromosomes and interphase nuclei analysed by chromosomalin situ suppression (CISS) hybridizationPrenatal Diagnosis, 1992